Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
COSCIENS Biopharma ( (TSE:CSCI) ) has issued an update.
On June 30, 2025, COSCIENS Biopharma Inc. announced the results of its virtual annual general and special meeting of shareholders. The meeting included the election of directors, the appointment of Deloitte LLP as the company’s auditor, and the approval of an ordinary resolution re-confirming the company’s Amended and Restated Shareholder Rights Plan. Additionally, COSCIENS leveraged an exemption from certain Canadian requirements regarding its long-term incentive plan, which did not require shareholder approval at the meeting. These developments are part of COSCIENS’ strategic positioning in the life sciences market, focusing on the development and commercialization of its diverse product portfolio.
More about COSCIENS Biopharma
COSCIENS Biopharma Inc. is a life sciences company that develops and commercializes a diverse portfolio of cosmeceutical, nutraceutical, and pharmaceutical products. The company employs proprietary extraction technology to produce active ingredients from renewable plant resources, which are used in cosmeceutical products and are being developed as potential nutraceuticals or pharmaceuticals. COSCIENS is listed on the NASDAQ Capital Market and the Toronto Stock Exchange under the ticker symbol ‘CSCI’.
YTD Price Performance: 15.27%
Average Trading Volume: 1,666
Technical Sentiment Signal: Sell
Current Market Cap: C$14.26M
See more data about CSCI stock on TipRanks’ Stock Analysis page.